CSF2 and lymphoma: We observed a similar priming of Aspergillus-induced ROS production with GM-CSF treatment ex vivo in neutrophils harvested from patients with lymphoma 3 days after treatment initiation with ibrutinib or acalabrutinib (Figure 7C).